Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and population health to address major health challenges. This…

Article by Julie Poucher Harbin: "Susan Blackwell: Navigating an Evolving Profession" (p.32)

In a lot of ways, Susan Blackwell (Crawford), MHS, PA-C’89, and the physician assistant profession have grown up together.

Fifty years since the National Cancer Act of 1971 declared “War on Cancer” and a decade since the first drug, an immunotherapy, was approved to treat metastatic melanoma, a leading clinician researcher goes head to head with metastatic melanoma.

The first annual Neil L. Spector Art of Medicine Award, which recognizes "exemplary mentorship practices in clinical and translational research," was presented last month to Kimberly Johnson, MD, MHS and Kim Huffman, MD, PhD.

Jen-Tsan Ashley Chi, MD, PhD, is co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence for his team paper: A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.

(This article was first published by the Duke Cancer Institute).

Charles Riggan, 68, (pictured above with clinical trial nurse coordinator Quinna Lawson) is well-known on the clinic floor for the Werther’s Original caramels he passes out during almost-weekly visits to Duke Cancer Center.

Thomas R. Cech, PhD, director of the BioFrontiers Institute at the University of Colorado Boulder, delivered the Paul L. Modrich, PhD, Distinguished Lecture on Friday at the Bryan Research Building to a packed auditorium of faculty and staff.

As a boy growing up in Schenectady, New York, Steven Patierno, PhD, could often be found out in the woods performing surgery on frogs, when he wasn’t playing sandlot soccer or a local, slightly more “aggressive” version of capture the flag.

Each year nearly 150,000 Americans are diagnosed with metastatic cancer that has spread to the brain. The number is projected to rise.

Three young Duke scientists who research cancer have been selected to attend the 68th Lindau Nobel Laureate Meeting in June, to be held in Germany.

Nearly 150,000 Americans annually are diagnosed with cancer that has metastasized, or traveled, to the brain. The number is projected to rise.